Why even i look for this company? Because i need vaccine and all here in my country. And guess what? Its Pfizer vaccine. So i made some research about it, and i think i will bought their stock but also need your opinion about it, im new in this so every help will be huge.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. More about them here.
Little about their finance:
Market Cap 202.487B
Forward Dividend & Yield :1.56 (4.30%)
In last 12 months they have total revenue of 41,908 and cost of revenue 8,574 so its GROSS PROFIT of 33,334
In February 2021, Pfizer and BioNTech dosed the first participant in a global Phase 2/3 study to further evaluate the safety, tolerability, and immunogenicity of the Pfizer-BioNTech COVID-19 vaccine in preventing COVID-19 in healthy pregnant women 18 years of age and older.
In March 2021, Pfizer and BioNTech dosed the first healthy children in a global Phase 1/2/3 continuous study to further evaluate the safety, tolerability, and immunogenicity of the Pfizer-BioNTech COVID-19 vaccine in children 11 years to 6 month old.
- Analysis of 927 confirmed symptomatic cases of COVID-19 demonstrates BNT162b2 is highly effective with 91.3% vaccine efficacy observed against COVID-19, measured seven days through up to six months after the second dose
- Vaccine was 100% effective in preventing severe disease as defined by the U.S. Centers for Disease Control and Prevention and 95.3% effective in preventing severe disease as defined by the U.S. Food and Drug Administration
- Vaccine was 100% effective in preventing COVID-19 cases in South Africa, where the B.1.351 lineage is prevalent
- Vaccine safety now evaluated in more than 44,000 participants 16 years of age and older, with more than 12,000 vaccinated participants having at least six months follow-up after their second dose
- The companies plan to share these results with worldwide regulatory agencies soon
Whats your opinion about it? Im gonna try it for sure.
Submitted April 04, 2021 at 08:21AM by Signal-Tradition8826 https://ift.tt/3upWBxd
